Human KLK13 ELISA Kit (V2LY-0626-LY3997)

Sumiya, R., Yamada, K., Hagiwara, T., Nagasaka, S., Miyazaki, H., Igari, T., & Kawamura, Y. I. (2023). Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma. Molecular and Clinical Oncology, 19(2), 1-7.

Shimomura, A., Hagiwara, T., Yamada, K., Yokoi, C., Terayama, M., Nohara, K., ... & Kawamura, Y. I. (2023). Induction of kallikrein-related peptidase 13 and TET2/3 by anticancer drugs and poor prognosis of patients with esophageal squamous cell carcinoma after preoperative treatment. Annals of Surgical Oncology, 1-11.

Gruba, N., Rachubik, P., Piwkowska, A., & Lesner, A. (2021). Analysis of urinary kallikrein-related peptidase 13 for monitoring bladder cancer. Biomarkers, 26(8), 770-779.

Milewska, A., Falkowski, K., Kalinska, M., Bielecka, E., Naskalska, A., Mak, P., ... & Pyrc, K. (2020). Kallikrein 13: a new player in coronaviral infections. biorxiv, 2020-03.

Milewska, A., Falkowski, K., Kulczycka, M., Bielecka, E., Naskalska, A., Mak, P., ... & Pyrc, K. (2020). Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1. Science signaling, 13(659), eaba9902.

Nohara, K., Yamada, K., Yamada, L., Hagiwara, T., Igari, T., Yokoi, C., ... & Kawamura, Y. I. (2018). Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma. General thoracic and cardiovascular surgery, 66, 351-357.

Gruba, N., Bielecka, E., Wysocka, M., Wojtysiak, A., Brzezińska-Bodal, M., Sychowska, K., ... & Lesner, A. (2019). Development of chemical tools to monitor human kallikrein 13 (KLK13) activity. International journal of molecular sciences, 20(7), 1557.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols